1. Home
  2. GNFT vs LWLG Comparison

GNFT vs LWLG Comparison

Compare GNFT & LWLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • LWLG
  • Stock Information
  • Founded
  • GNFT 1999
  • LWLG 1991
  • Country
  • GNFT France
  • LWLG United States
  • Employees
  • GNFT N/A
  • LWLG N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • LWLG Containers/Packaging
  • Sector
  • GNFT Health Care
  • LWLG Industrials
  • Exchange
  • GNFT Nasdaq
  • LWLG Nasdaq
  • Market Cap
  • GNFT 296.4M
  • LWLG 333.2M
  • IPO Year
  • GNFT 2019
  • LWLG N/A
  • Fundamental
  • Price
  • GNFT $4.23
  • LWLG $2.72
  • Analyst Decision
  • GNFT Strong Buy
  • LWLG
  • Analyst Count
  • GNFT 1
  • LWLG 0
  • Target Price
  • GNFT $13.00
  • LWLG N/A
  • AVG Volume (30 Days)
  • GNFT 7.5K
  • LWLG 850.1K
  • Earning Date
  • GNFT 09-19-2024
  • LWLG 11-13-2024
  • Dividend Yield
  • GNFT N/A
  • LWLG N/A
  • EPS Growth
  • GNFT N/A
  • LWLG N/A
  • EPS
  • GNFT 0.47
  • LWLG N/A
  • Revenue
  • GNFT $86,225,222.00
  • LWLG $113,190.00
  • Revenue This Year
  • GNFT $155.44
  • LWLG N/A
  • Revenue Next Year
  • GNFT N/A
  • LWLG N/A
  • P/E Ratio
  • GNFT $8.98
  • LWLG N/A
  • Revenue Growth
  • GNFT 175.45
  • LWLG N/A
  • 52 Week Low
  • GNFT $3.08
  • LWLG $2.44
  • 52 Week High
  • GNFT $6.42
  • LWLG $5.69
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 27.92
  • LWLG 39.97
  • Support Level
  • GNFT $4.17
  • LWLG $2.71
  • Resistance Level
  • GNFT $4.45
  • LWLG $3.06
  • Average True Range (ATR)
  • GNFT 0.14
  • LWLG 0.28
  • MACD
  • GNFT -0.10
  • LWLG -0.07
  • Stochastic Oscillator
  • GNFT 3.66
  • LWLG 4.84

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About LWLG Lightwave Logic Inc.

Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.

Share on Social Networks: